Ying Xiang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 9
Ying Xiang
104 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 526
- Molecular Medicine 97
- Internal Medicine 68
- Cardiology and Cardiovascular Medicine 345
- Endocrinology 67
Countries citing papers authored by Ying Xiang
This map shows the geographic impact of Ying Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Xiang more than expected).
Fields of papers citing papers by Ying Xiang
This network shows the impact of papers produced by Ying Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Xiang. The network helps show where Ying Xiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 23 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 11 | |
| 14 | 2020 | 27 | |
| 15 | 2019 | 6 | |
| 16 | 2019 | 26 | |
| 17 | 2018 | 11 | |
| 18 | 2016 | 33 | |
| 19 | 2015 | 37 | |
| 20 | 2011 | 0 |
About Ying Xiang
Ying Xiang is a scholar working on Developmental Biology, Molecular Medicine, Cancer Research, Endocrinology and Internal Medicine, having authored 107 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (10 papers), Antibiotic Resistance in Bacteria (9 papers), Circular RNAs in diseases (9 papers), Salmonella and Campylobacter epidemiology (8 papers), Atrial Fibrillation Management and Outcomes (8 papers), COVID-19 Clinical Research Studies (8 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (526 citations), Molecular Medicine (97 citations), Internal Medicine (68 citations), Cardiology and Cardiovascular Medicine (345 citations) and Endocrinology (67 citations). Ying Xiang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yafei Li, Na Wu, Long Wu, Chengying Li, Weijia Xie, Li Zhong, Zubin Yu, Qingyun Liu, Xiangyu Ma and Lin Fu. Their work appears in journals such as Frontiers in Microbiology, Scientific Reports, Cancer Biomarkers, Environmental Science and Pollution Research and World Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.